The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2026
Predictive value of homocysteine and blood lipid levels in late pregnancy for neonatal outcomes in women with hypertensive disorders of pregnancy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pan Zhiyu, Liu Chunling, He Jinlan
Аннотация
OBJECTIVE: This study aimed to investigate the correlations of late-pregnancy homocysteine (Hcy) and lipid profiles with disease severity in hypertensive disorders of pregnancy (HDP) and evaluate their predictive value for subsequent neonatal outcomes.
METHODS: In total, 156 patients with HDP (61 with gestational hypertension [GH] and 95 with preeclampsia [PE]) were retrospectively analyzed. Clinical characteristics and laboratory parameters, including Hcy and blood lipid profiles, were collected. Logistic regression and subgroup analyses were used to identify the factors related to adverse neonatal outcomes, and receiver operating characteristic (ROC) curves were applied to assess their predictive performance.
RESULTS: Significant differences in systolic blood pressure, Hcy, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, total cholesterol (TC), triglyceride (TG), and albumin levels were observed between the GH and PE groups. Based on subgroup analyses and logistic regression data, increased Hcy, TC, and TG levels were independently associated with PE status. Additionally, higher late-pregnancy Hcy and TG levels and lower late-pregnancy HDL-C levels were significantly associated with an increased risk of adverse neonatal outcomes. The combined detection of Hcy, TG, and HDL-C demonstrated better predictive performance (the area under the ROC curve = 0.874, 95% CI: 0.812-0.922) than every single detection.
CONCLUSION: Elevated Hcy and TG levels and reduced HDL-C levels in the late pregnancy are significantly associated with disease severity and adverse neonatal outcomes in HDP. Combined assessment of these biomarkers may serve as a useful adjunct for predicting adverse neonatal outcomes.
METHODS: In total, 156 patients with HDP (61 with gestational hypertension [GH] and 95 with preeclampsia [PE]) were retrospectively analyzed. Clinical characteristics and laboratory parameters, including Hcy and blood lipid profiles, were collected. Logistic regression and subgroup analyses were used to identify the factors related to adverse neonatal outcomes, and receiver operating characteristic (ROC) curves were applied to assess their predictive performance.
RESULTS: Significant differences in systolic blood pressure, Hcy, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, total cholesterol (TC), triglyceride (TG), and albumin levels were observed between the GH and PE groups. Based on subgroup analyses and logistic regression data, increased Hcy, TC, and TG levels were independently associated with PE status. Additionally, higher late-pregnancy Hcy and TG levels and lower late-pregnancy HDL-C levels were significantly associated with an increased risk of adverse neonatal outcomes. The combined detection of Hcy, TG, and HDL-C demonstrated better predictive performance (the area under the ROC curve = 0.874, 95% CI: 0.812-0.922) than every single detection.
CONCLUSION: Elevated Hcy and TG levels and reduced HDL-C levels in the late pregnancy are significantly associated with disease severity and adverse neonatal outcomes in HDP. Combined assessment of these biomarkers may serve as a useful adjunct for predicting adverse neonatal outcomes.